AstraZeneca and Oxford University

South African Strain “Flooding In The Back Door”, Warns Vaccine Team

According to Sir John, the continent had ‘no idea’ what was going on in terms of how strains were spreading, reports The Telegraph.

Hopeless response

Europe’s “hopeless” response to Covid-19 has meant Britain risks the South African strain “flooding in the back door” when travel resumes, making it impossible for vaccines to curb the spread of the virus, a leading member of the Oxford AstraZeneca vaccine team has said.

The third wave

Sir John Bell was speaking days after the Government attempted to...

https://mfame.guru/south-african-strain-flooding-in-the-back-door-warns-vaccine-team/

Oxford Vaccine 79% Effective With No Blood Clot Risk, Finds US Trial

  • A long pertaining US trial of the Oxford COVID vaccine has revealed that the vaccine is effective in all. 
  • It dispelled all rumours of Venous sinus thrombosis or blood clots in the brain. 
  • This particular side effect led to the cancellation of the vaccine in Europe earlier this month.
  • This huge study conducted in older people revealed that the vaccine is effective in the old and across all ethnic groups. 

According to a Guardian report, the Covid-19 vaccine developed by Oxford University and...

https://mfame.guru/oxford-vaccine-79-effective-with-no-blood-clot-risk-finds-us-trial/

UK Vaccination Drive Hit With Supply Delays Over the Coming Weeks

  • Britain is facing a squeeze on supply of COVID-19 vaccines next month in part due to a delay in a shipment from India’s Serum Institute that is making AstraZeneca’s shot.
  • British health officials warned that the world’s fastest big economy roll-out of the vaccine would face a significant reduction in supplies from March 29.

An expected reduction in the UK’s Covid vaccine supply in April is partly due to a delay in a delivery from India of five million Oxford-AstraZeneca doses, reports BBC.

Delay...

https://mfame.guru/uk-vaccination-drive-hit-with-supply-delays-over-the-coming-weeks/

NI Continues In AstraZeneca Vaccination Jab Despite Irish Suspension

Health officials in Northern Ireland will continue to use the Oxford-AstraZeneca vaccine after its suspension in the Republic of Ireland, says an article published in BBC.

Clotting precautionary

The country’s National Immunisation Advisory Committee (NIAC) recommended the move after reports of serious blood clotting events in adults in Norway.

Ireland’s Health Minister Stephen Donnelly said it was “precautionary”.

AstraZeneca said there is no evidence of a link between the vaccine and increased...

https://mfame.guru/ni-continues-in-astrazeneca-vaccination-jab-despite-irish-suspension/

WHO Approves Oxford COVID Vaccine Saying Benefits Outweighs Risks

  • WHO has approved AstraZeneca covid vaccines.
  • Studies show benefits outweigh risks.
  • The vaccine will be supplied through the global COVAX.
  • This is the 3rd vaccine to receive WHO approval
  • Meanwhile, Oxford researchers are starting the vaccine trials on children.

According to an ANI News report, the World Health Organisation (WHO) on Monday gave emergency use approval (EUA) to two versions of AstraZeneca-Oxford-developed COVID-19 vaccines, allowing these shots to be rolled out globally through...

https://mfame.guru/who-approves-oxford-covid-vaccine-saying-benefits-outweighs-risks/

Covid 19 Vaccine Stopped, Less Effective Against New Strain

  • Drugmaker AstraZeneca is racing to adapt its Covid-19 vaccine in the face of new variants of the virus.
  • The process has become more urgent after the outcome of a small-scale study.
  • The study found that it was less effective at protecting against the more virulent strain discovered in South Africa.
  • Vaccine makers are working on second-generation shots to target variants.

A recent news article published in CNBC reveals that AstraZeneca races to adapt Covid vaccine to variant as South Africa...

https://mfame.guru/covid-19-vaccine-stopped-less-effective-against-new-strain/

Experts Warn of Jumping Conclusions As COVID Oxford Vaccine Rollout Halted

According to a BBC report, South Africa has put its rollout of the Oxford-AstraZeneca vaccine on hold after a study showed “disappointing“ results against its new Covid variant.

  • Scientists say the variant accounts for 90% of new Covid cases in South Africa.
  • The trial, involving some 2,000 people, found that the vaccine offered “minimal protection“ against mild and moderate cases.
  • But experts are hopeful that the vaccine will still be effective at preventing severe cases.

South Africa has...

https://mfame.guru/experts-warn-of-jumping-conclusions-as-covid-oxford-vaccine-rollout-halted/

Join Our Newsletter
Enter your email to receive a weekly round-up of shipping news.
icon
By subscribing, you agree with our privacy policy and our terms of service.